chemical:lixisenatide
Adlyxin's 2025 Patent expiry
Aldyxin' approaching 2025 patent expiry and what it could mean for new GLP1 drugs.
GLP1.Guide Staff
Scouring sources for information on GLP1 Agonist drugs, so you don't have to.
categeory:watercooler
Research models applied to GLP1s and Plateaus
New research that shows a benefit to appetite feedback control circuits via mathematical modeling, showing the benefits of using GLP1s.
22.7% weight loss yet Novo Nordisk stock drops 27%
Novo Nordisk's new CagriSema drug showed weight loss results that are *stunning*, but less than what Wall Street expected.
chemical:semaglutide
Semaglutide & Liraglutide continue to be effective
Semaglutide and Liraglutide continue to be researched and studied and produce positive results for weight loss and medical outcomes.
category:watercooler
Lizzo's as a lens on GLP1 public opinion
We view the the reflection of public opinion on GLP1s and drugs like Ozempic, Mounjaro, and Zepbound through an unusual lens: Lizzo.
company:eli-lilly
Eli Lilly brands GLP1s as "anti-hedonics"
Eli Lilly leans into the use of GLP1s for reducing addictive behavior, labeling them "anti-hedonics"
category:watercooler
How much are people paying for GLP1s? (2024/11)
We take another look at reports of what people are paying for GLP1s with/without insurance and everywhere in between.
category:factsheet
A list of FDA approved GLP1s
A list of FDA approved GLP1 Receptor Agonists (Ozempic, Wegovy, Mounjaro, etc), for easy reference.
category:side-effects
Anxiety and suicidal thoughts after stopping GLP1s?
Reports of anxiety and suicidal reports have been reported for people after *stopping* use of GLP1s. We dig in, and weight the FDA's comments.
government
Biden-Harris administration keen on GLP1s
The outgoing Biden-Harris admin puts out a proposal on widening access to GLP1s, which we hope the incoming Trump admin will also adopt.
category:watercooler
Weight loss "stalling" on GLP1s?
What happens when weight loss stalls on GLP1s? We check around the GLP1 community to see what people have figured out.
country:uk
The UK's bet on GLP1
A look at the UK's growing evaluation and use of GLP1 receptor agonists -- Ozempic, Mounjaroy, Wegovy, Zepbound and more.